Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Testis Cancer
100%
Bladder
92%
Chemotherapy
90%
Transitional Cell Carcinoma
88%
Prostate Cancer
87%
Clear Cell Renal Cell Carcinoma
87%
Orchiectomy
80%
Retroperitoneal Lymph Node Dissection
78%
Diseases
73%
Bladder Cancer
69%
Testes
57%
Recurrent Disease
55%
Testis Tumor
54%
Prostatectomy
53%
Urinary Tract
44%
Germ Cell Cancer
44%
Radical Nephrectomy
43%
Neoplasm
42%
Clinical Stage
41%
Cystoscopy
40%
Urologist
39%
Chylous Ascites
39%
Vesicoureteral Reflux
38%
Cystography
37%
Metastatic Carcinoma
37%
Dentigerous Cyst
34%
Continence
34%
Urinary System
33%
Necrosis
33%
Conservative Treatment
33%
Ureter Obstruction
32%
Adolescence
32%
Hyperthermia
31%
Etiology
31%
Ureter
30%
Urine Cytology
30%
Hematuria
28%
Surgical Exploration
28%
Non Seminomatous Germinoma
28%
Non Muscle Invasive Bladder Cancer
27%
Urine Sampling
27%
Tumor
27%
Radical Retropubic Prostatectomy
26%
Adrenalectomy
26%
Appendectomy
26%
Prostate Hypertrophy
26%
Fluorescence in Situ Hybridization
26%
Pectin
26%
Positron Emission Tomography-Computed Tomography
26%
Mycobacterium Bovis BCG
26%
Keyphrases
Renal Cell Carcinoma
89%
Testis Cancer
83%
Orchiectomy
72%
Nonseminomatous
67%
Testicular Germ Cell Tumor
56%
Bladder Cancer
49%
Prostate Cancer
46%
Low Stage
45%
Radical Prostatectomy
45%
Testicle
43%
Bladder
43%
Post-chemotherapy Retroperitoneal Lymph Node Dissection
42%
Urologists
41%
Non-muscle Invasive Bladder Cancer (NMIBC)
41%
Cystoscopy
41%
Chylous Ascites
39%
Vesicoureteral Reflux
39%
Radical Retropubic Prostatectomy
39%
Ureteral Obstruction
39%
Metastasis
39%
Cystography
35%
Tumor
35%
Retroperitoneal Lymph Node Dissection (RPLND)
34%
Hyperthermia
32%
Prostate Cancer Patients
32%
Prostatic Adenocarcinoma
32%
Teratoma
32%
Urine Cytology
31%
Radical Nephrectomy
31%
Etiology
29%
Indiana
29%
Elderly Patients
29%
Surgical Exploration
28%
Urine Samples
28%
Voided Urine
28%
Continence
28%
Urethra
27%
Negative Predictive Value
27%
Malignancy
27%
Intravesical
26%
Hematuria
26%
Non-metastatic Biochemically Relapsed Prostate Cancer
26%
Bladder Transitional Cell Carcinoma
26%
Adrenalectomy
26%
Young Women
26%
Benign Prostatic Hyperplasia
26%
Modified Citrus Pectin
26%
Extensive Necrosis
26%
Nonseminomatous Germ Cell Cancer
26%
Bacillus Calmette-Guérin
26%